[go: up one dir, main page]

Lee et al., 1997 - Google Patents

Inhibitory effect of heparin on serotonin-induced hyperplasia and hypertrophy of smooth muscle cells

Lee et al., 1997

View PDF @Full View
Document ID
340504622372804904
Author
Lee S
Wang W
Joseph P
Hales C
Fanburg B
Publication year
Publication venue
American journal of respiratory cell and molecular biology

External Links

Snippet

Serotonin (5-HT) produces both hyperplastic and hypertrophic effects on smooth muscle cell (SMC) in culture. Heparin is known to inhibit serum-induced hyperplasia of SMC but has not been previously tested on the stimulatory effect of 5-HT on SMC. Our present data show that …
Continue reading at www.atsjournals.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Similar Documents

Publication Publication Date Title
Mornex et al. Spontaneous expression of the c-sis gene and release of a platelet-derived growth factorlike molecule by human alveolar macrophages.
Villa et al. Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury
Wickel et al. Poor outcome from peritonitis is caused by disease acuity and organ failure, not recurrent peritoneal infection
Naftilan et al. Angiotensin II induces c-fos expression in smooth muscle via transcriptional control.
Eder Jr et al. Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily
Ankara Rheumatology Study Group et al. A multicenter study of patients with adult-onset Still’s disease compared with systemic juvenile idiopathic arthritis
Maloney et al. In vitro release of vascular endothelial growth factor during platelet aggregation
Gupta et al. BiP/GRP78 is an intracellular target for MDA-7/IL-24 induction of cancer-specific apoptosis
Laudes et al. Expression and function of C5a receptor in mouse microvascular endothelial cells
Gruber et al. Endogenous digitalis-like substance in plasma of volume-expanded dogs
Sousa et al. Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects
Rao et al. Polyamines regulate intestinal epithelial restitution through TRPC1-mediated Ca2+ signaling by differentially modulating STIM1 and STIM2
Binamé et al. Disruption of Sema3A/Plexin‐A1 inhibitory signalling in oligodendrocytes as a therapeutic strategy to promote remyelination
Kavanaugh et al. Effect of acute alcohol ingestion prior to burn injury on intestinal bacterial growth and barrier function
Ohbayashi et al. Induction of pulmonary fibrosis by methotrexate treatment in mice lung in vivo and in vitro
Jumbe et al. Quinolone efflux pumps play a central role in emergence of fluoroquinolone resistance in Streptococcus pneumoniae
Németh et al. NHE blockade inhibits chemokine production and NF-κB activation in immunostimulated endothelial cells
Tohme et al. Moesin functions as a lipopolysaccharide receptor on human monocytes
Glaser-Gabay et al. Endothelial cell surface vimentin binding peptide induces angiogenesis under hypoxic/ischemic conditions
Lee et al. Inhibitory effect of heparin on serotonin-induced hyperplasia and hypertrophy of smooth muscle cells
Yu et al. Neuropilin-1 is a novel host factor modulating the entry of hepatitis B virus
McArthur et al. Mode of action of antirheumatic drugs
Arcot et al. Basic fibroblast growth factor alterations during development of monocrotaline-induced pulmonary hypertension in rats
Demir et al. Collagen VI status and clinical severity in Ullrich congenital muscular dystrophy: phenotype analysis of 11 families linked to the COL6 loci
Meltzer et al. Enhanced immunohistochemical detection of autonomic nerve fibers, cytokines and inducible nitric oxide synthase by light and fluorescent microscopy in rat spleen